Basit öğe kaydını göster

dc.contributor.authorFambiatos, Adam
dc.contributor.authorJokubaitis, Vilija
dc.contributor.authorHorakova, Dana
dc.contributor.authorHavrdova, Eva Kubala
dc.contributor.authorTrojano, Maria
dc.contributor.authorPrat, Alexandre
dc.contributor.authorTurkoglu, Recai
dc.date.accessioned2020-06-21T12:26:11Z
dc.date.available2020-06-21T12:26:11Z
dc.date.issued2020
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.urihttps://doi.org/10.1177/1352458519868990
dc.identifier.urihttps://hdl.handle.net/20.500.12712/10681
dc.descriptionTurkoglu, Recai/0000-0001-9724-851X; Ferraro, Diana/0000-0003-4818-3806; McCombe, Pamela/0000-0003-2704-8517; Altintas, Ayse/0000-0002-8524-5087; Jokubaitis, Vilija G./0000-0002-3942-4340; Slee, Mark/0000-0003-4323-2453; Lugaresi, Alessandra/0000-0003-2902-5589; van Pesch, Vincent/0000-0003-2885-9004; Vucic, Steve/0000-0002-8323-873Xen_US
dc.descriptionWOS: 000481049900001en_US
dc.descriptionPubMed: 31397221en_US
dc.description.abstractBackground: The risk factors for conversion from relapsing-remitting to secondary progressive multiple sclerosis remain highly contested. Objective: The aim of this study was to determine the demographic, clinical and paraclinical features that influence the risk of conversion to secondary progressive multiple sclerosis. Methods: Patients with adult-onset relapsing-remitting multiple sclerosis and at least four recorded disability scores were selected from MSBase, a global observational cohort. The risk of conversion to objectively defined secondary progressive multiple sclerosis was evaluated at multiple time points per patient using multivariable marginal Cox regression models. Sensitivity analyses were performed. Results: A total of 15,717 patients were included in the primary analysis. Older age (hazard ratio (HR) = 1.02, p < 0.001), longer disease duration (HR = 1.01, p = 0.038), a higher Expanded Disability Status Scale score (HR = 1.30, p < 0.001), more rapid disability trajectory (HR = 2.82, p < 0.001) and greater number of relapses in the previous year (HR = 1.07, p = 0.010) were independently associated with an increased risk of secondary progressive multiple sclerosis. Improving disability (HR = 0.62, p = 0.039) and disease-modifying therapy exposure (HR = 0.71, p = 0.007) were associated with a lower risk. Recent cerebral magnetic resonance imaging activity, evidence of spinal cord lesions and oligoclonal bands in the cerebrospinal fluid were not associated with the risk of conversion. Conclusion: Risk of secondary progressive multiple sclerosis increases with age, duration of illness and worsening disability and decreases with improving disability. Therapy may delay the onset of secondary progression.en_US
dc.description.sponsorshipNational Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [1083539, 1129189, 1140766]; BiogenBiogen; RocheRoche Holding; Bayer ScheringBayer AG; Sanofi Genzyme; Teva; MerckMerck & Company; NovartisNovartisen_US
dc.description.sponsorshipThe author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was financially supported by National Health and Medical Research Council of Australia (project grants 1083539 and 1129189 and fellowship 1140766). The MSBase Foundation is a not-for-profit organisation that receives support from Merck, Biogen, Roche, Novartis, Bayer Schering, Sanofi Genzyme and Teva. The study was conducted separately and apart from the guidance of the sponsors.en_US
dc.language.isoengen_US
dc.publisherSage Publications Ltden_US
dc.relation.isversionof10.1177/1352458519868990en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSPMSen_US
dc.subjectmultiple sclerosisen_US
dc.subjectdisease modifying therapiesen_US
dc.subjectpredictionen_US
dc.subjectprognosticsen_US
dc.titleRisk of secondary progressive multiple sclerosis: A longitudinal studyen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume26en_US
dc.identifier.issue1en_US
dc.identifier.startpage79en_US
dc.identifier.endpage90en_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster